Skip to Content

Astrana Health Inc ASTH

Morningstar Rating
$37.93 +1.21 (3.30%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ASTH is trading at a 14% discount.
Price
$36.84
Fair Value
$48.37
Uncertainty
High
1-Star Price
$51.13
5-Star Price
$37.18
Economic Moat
Gdxt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ASTH is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$36.72
Day Range
$36.8338.02
52-Week Range
$28.8745.71
Bid/Ask
$15.26 / $60.30
Market Cap
$1.72 Bil
Volume/Avg
85,938 / 156,676

Key Statistics

Price/Earnings (Normalized)
24.39
Price/Sales
1.28
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.60%

Company Profile

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Small Growth
Total Number of Employees
1,800

Comparables

Valuation

Metric
ASTH
PIII
AGL
Price/Earnings (Normalized)
24.390.06
Price/Book Value
2.890.383.15
Price/Sales
1.280.110.49
Price/Cash Flow
19.44
Price/Earnings
ASTH
PIII
AGL

Financial Strength

Metric
ASTH
PIII
AGL
Quick Ratio
2.030.531.46
Current Ratio
2.110.551.51
Interest Coverage
5.70−10.49−28.21
Quick Ratio
ASTH
PIII
AGL

Profitability

Metric
ASTH
PIII
AGL
Return on Assets (Normalized)
7.43%−20.64%−5.02%
Return on Equity (Normalized)
12.90%−461.86%−11.33%
Return on Invested Capital (Normalized)
9.45%−29.07%−10.18%
Return on Assets
ASTH
PIII
AGL
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA
HCA Healthcare IncBpllcwltYzpylcz$82.4 Bil
FSNUY
Fresenius SE & Co KGaA ADRQyfrrb$16.7 Bil
FSNUF
Fresenius SE & Co KGaARpqgj$16.7 Bil
BDUUY
Bangkok Dusit Medical Services PCL ADRYthb$12.3 Bil
FMCQF
Fresenius Medical Care AGNsrpyq$12.1 Bil
FMS
Fresenius Medical Care AG ADRNgzwJbqnjmp$12.1 Bil
DVA
DaVita IncBbcnrzntSybzxm$12.1 Bil
UHS
Universal Health Services Inc Class BVpkfhq$11.4 Bil
THC
Tenet Healthcare CorpHdrswxwJwbz$9.8 Bil
AMN
AMN Healthcare Services IncXrlctpttmXwmbxh$2.3 Bil

Sponsor Center